Cleveland BioLabs

$1.07
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.05 (4.90%) Today
$0.00 (0.00%) As of 3:46 PM EDT after-hours

Why Robinhood?

You can buy or sell CBLI and other stocks, options, ETFs, and crypto commission-free!

About CBLI

Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. Read More It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY.

Employees
16
Headquarters
Buffalo, New York
Founded
2003
Market Cap
12.09M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
17.11K
High Today
$1.08
Low Today
$1.01
Open Price
$1.01
Volume
4.75K
52 Week High
$2.16
52 Week Low
$1.00

Collections

CBLI Earnings

-$0.11
-$0.09
-$0.06
-$0.04
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 13, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.